StockData

Johnson & Johnson vs Novo Nordisk A S

JNJ and NVO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How JNJ and NVO compare

Johnson & Johnson grew revenue faster over the last twelve months (7.8% versus 6.4% for Novo Nordisk A S).

Johnson & Johnson pays a dividend yielding 1.9%; Novo Nordisk A S does not pay one.

Johnson & Johnson scores higher on the StockData Score (12 against 4 for Novo Nordisk A S), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricJNJNVO
Size and price
Market cap$671B–
Share price$278.70$40.70
Change, 1 year42.2%−15.7%
Change, 5 years75.1%−24.7%
Beta (5Y)−0.300.76
Employees138K70K
StockData Score
Total score12 (better)4
Valuation score00
Growth score3 (better)2
Performance score4 (better)0
Health score3 (better)2
Dividend score2 (better)0
Valuation
P/E42.3×–
P/S6.8×–
P/B8.2×–
EV/EBITDA26.0×–
P/FCF32.6×–
PEG2.36–
FCF yield3.1%–
Fair value$150.10–
Margin of safety−85.7%–
Growth
Revenue growth (TTM)7.8% (better)6.4%
Revenue growth, 5Y average2.7%19.5% (better)
Net income growth (TTM)−35.9%–
EPS growth (TTM)−36.4%1.8% (better)
EPS growth, 5Y average14.9%20.7% (better)
Profitability
Gross margin67.6%81.0% (better)
Operating margin–41.3%
Net margin16.2%–
FCF margin20.7% (better)19.1%
Return on equity20.0%–
Financial health
Debt / equity0.55–
Net debt / EBITDA1.020.82 (better)
Interest coverage–18.8×
Current ratio1.02 (better)0.80
Altman Z-score5.18–
Piotroski F-score4–
Dividends and buybacks
Dividend yield1.9%–
Years of dividend growth16–
Dividend growth, 5Y average5.2%–
Buyback yield1.2%–
Shareholder yield3.1%–
Ownership
Held by institutions74.8%7.3%
Held by insiders0.04%0.00%
Insider net buying, 12 months−$154M–
Superinvestors holding6 (better)1
Short interest, % of float0.71%–

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.